Magali Taiel
Chief Tech/Sci/R&D Officer bei GENSIGHT BIOLOGICS S.A.
Profil
Dr. Magali Taiel, MD, is a Chief Medical Officer at Gensight Biologics SA. Dr. Taiel was previously employed as a Vice President-Clinical Development by ProQR Therapeutics NV and a Project Manager by Servier SAS.
She received her doctorate degree from Universite Paris Cite.
Aktive Positionen von Magali Taiel
Unternehmen | Position | Beginn |
---|---|---|
GENSIGHT BIOLOGICS S.A. | Chief Tech/Sci/R&D Officer | 08.10.2019 |
Ehemalige bekannte Positionen von Magali Taiel
Unternehmen | Position | Ende |
---|---|---|
PROQR THERAPEUTICS N.V. | Corporate Officer/Principal | 01.09.2018 |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Magali Taiel
Universite Paris Cite | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENSIGHT BIOLOGICS S.A. | Health Technology |
PROQR THERAPEUTICS N.V. | Health Technology |
Private Unternehmen | 1 |
---|---|
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Commercial Services |